Farallon Capital Management, L.l.c.
San Francisco, CA 87 processed 13Fs on this site, 2021 Q3 to 2026 Q2
- $21.7B
- 77 holdings
- 2026 Q2
- +23.6% QoQ
- Top 5 29.9%
AUM over time
Book
| RVMD, Revolution Medicines | Reduce −6.7% | 13,604,796 | $97.25 | $1.3B | −978,000 | +$162M | |
| AMZN, Amazon | Reduce −6.3% | 4,218,394 | $208.27 | $879M | −281,500 | −$160M | |
| MSFT, Microsoft | Add +5.9% | 2,344,779 | $370.17 | $868M | +130,700 | −$203M | |
| AON, Aon | Reduce −5.7% | 2,512,638 | $322.78 | $811M | −152,600 | −$129M | |
| BBIO, Bridgebio | Add +4.1% | 9,365,463 | $74.26 | $695M | +367,000 | +$7.2M | |
| PTGX, Protagonist Therapeutics | Add +3.3% | 6,348,906 | $105.40 | $669M | +204,900 | +$133M | |
| NTRA, Natera | Reduce −18.1% | 3,207,366 | $199.99 | $641M | −707,000 | −$255M | |
| EXEL, Exelixis | Reduce −16.5% | 13,111,010 | $42.89 | $562M | −2,598,490 | −$126M | |
| AVGO, Broadcom | Add +99.4% | 1,779,500 | $309.51 | $551M | +887,100 | +$242M | |
| UNH, UnitedHealth Group | Add +13.9% | 1,821,706 | $270.59 | $493M | +222,800 | −$35M | |
| SNPS, Synopsys | Add +21.4% | 1,213,300 | $396.48 | $481M | +214,100 | +$12M | |
| BSX, Boston Scientific | Add +0.4% | 7,470,684 | $62.75 | $469M | +31,120 | −$241M | |
| TMO, Thermo Fisher Scientific | Add +38.7% | 881,485 | $491.53 | $433M | +245,800 | +$65M | |
| KKR | Add +131.5% | 4,671,800 | $92.50 | $432M | +2,654,100 | +$175M | |
| LNTH, Lantheus | Add +2.9% | 5,583,479 | $75.85 | $424M | +156,000 | +$62M | |
| WAB, Wabtec | Reduce −35.0% | 1,609,403 | $249.91 | $402M | −866,600 | −$126M | |
| SCHW, Charles Schwab | Add +18.4% | 3,955,657 | $93.98 | $372M | +616,000 | +$38M | |
| LQDA, Liquidia | Hold | 8,656,038 | $37.74 | $327M | — | — | |
| CRNX | Add +20.3% | 8,338,098 | $36.32 | $303M | +1,405,000 | −$20M | |
| GOOG, Alphabet | Add +26.6% | 996,231 | $286.86 | $286M | +209,191 | +$39M | |
| ROIV, Roivant Sciences | Add +26048.6% | 9,675,000 | $27.70 | $268M | +9,638,000 | +$267M | |
| V, Visa | Add +20.8% | 840,710 | $302.24 | $254M | +144,800 | +$10M | |
| ARMK, Aramark | Reduce −34.4% | 6,135,431 | $40.54 | $249M | −3,221,615 | −$96M | |
| BEAM, Beam Therapeutics | Add +0.7% | 10,134,696 | $23.83 | $242M | +71,585 | −$37M | |
| DIS, Disney | Reduce −41.8% | 2,401,591 | $96.38 | $231M | −1,724,400 | −$238M | |
| MA, Mastercard | Add +152.0% | 435,071 | $499.66 | $217M | +262,400 | +$119M | |
| MCK, McKesson | Reduce −21.6% | 234,300 | $865.36 | $203M | −64,600 | −$42M | |
| AGIO, Agios Pharmaceuticals | Add +10.2% | 5,684,000 | $33.83 | $192M | +524,495 | +$52M | |
| CNTA, Centessa Pharmaceuticals | Reduce −10.6% | 4,809,000 | $39.72 | $191M | −568,068 | +$57M | |
| TNGX, Tango Therapeutics | Reduce −30.3% | 9,097,411 | $20.92 | $190M | −3,964,000 | +$75M | |
| GRAL, Grail | Add +38.9% | 3,253,684 | $51.68 | $168M | +911,000 | −$32M | |
| TYRA, Tyra Biosciences | Add +73.3% | 3,580,818 | $38.30 | $137M | +1,514,000 | +$83M | |
| THC, Tenet Healthcare | Add +21.5% | 452,153 | $188.71 | $85M | +80,000 | +$11M | |
| CAH, Cardinal Health | Reduce −36.1% | 368,000 | $211.31 | $78M | −208,000 | −$41M | |
| PCVX, Vaxcyte | Add +25120.0% | 1,261,000 | $58.11 | $73M | +1,256,000 | +$73M | |
| DNTH, Dianthus Therapeutics | New | 836,000 | $83.92 | $70M | +836,000 | +$70M | |
| BTSG, Brightspring Health Services | Add +7250.0% | 1,617,000 | $42.61 | $69M | +1,595,000 | +$68M | |
| TWST, Twist Bioscience | Add +18562.1% | 1,427,650 | $47.52 | $68M | +1,420,000 | +$68M | |
| BIDU, Baidu | Add +40.8% | 443,785 | $111.42 | $49M | +128,485 | +$8.2M | |
| CGON, CG Oncology | Add +8325.0% | 674,000 | $67.68 | $46M | +666,000 | +$45M | |
| AZN, AstraZeneca | New | 226,499 | $197.22 | $45M | +226,499 | +$45M | |
| MRK, Merck | New | 361,000 | $120.29 | $43M | +361,000 | +$43M | |
| ACHC | New | 1,736,800 | $23.39 | $41M | +1,736,800 | +$41M | |
| WELL, Welltower | Reduce −41.7% | 200,000 | $197.71 | $40M | −143,000 | −$24M | |
| IMVT, Immunovant | Add +12783.3% | 1,546,000 | $24.84 | $38M | +1,534,000 | +$38M | |
| ENTA, Enanta Pharmaceuticals | Add +3.6% | 2,871,862 | $12.63 | $36M | +99,600 | −$7.4M | |
| JNJ, Johnson & Johnson | New | 148,000 | $244.44 | $36M | +148,000 | +$36M | |
| BBNX, Beta Bionics | Reduce −16.4% | 3,607,920 | $10.02 | $36M | −706,000 | −$95M | |
| ASMB, Assembly Biosciences | Hold | 1,227,590 | $27.75 | $34M | — | — | |
| JOYY | Hold | 578,200 | $58.39 | $34M | — | — | |
| NTES, NetEase | New | 291,219 | $111.94 | $33M | +291,219 | +$33M | |
| NVO, Novo Nordisk | New | 782,000 | $36.75 | $29M | +782,000 | +$29M | |
| BITW, Bitwise 10 Crypto Index ETF | Reduce −82.2% | 603,000 | $44.61 | $27M | −2,782,500 | −$172M | |
| PCSC, Perceptive Cap Solutions | Hold | 2,250,000 | $10.97 | $25M | — | — | |
| RPRX | New | 493,000 | $47.97 | $24M | +493,000 | +$24M | |
| NERV, Minerva Neurosciences | Hold | 2,365,000 | $6.02 | $14M | — | — | |
| CECO, Ceco Environmental | New | 234,000 | $59.58 | $14M | +234,000 | +$14M | |
| AVTX, Avalo Therapeutics | New | 916,000 | $14.93 | $14M | +916,000 | +$14M | |
| GDS, GDS Holdings | New | 292,000 | $40.29 | $12M | +292,000 | +$12M | |
| MAZE, Maze Therapeutics | New | 373,000 | $29.85 | $11M | +373,000 | +$11M | |
| TEVA, Teva Pharmaceutical Industries | Add +785.0% | 354,000 | $30.12 | $11M | +314,000 | +$9.4M | |
| FORM, Formfactor | New | 56,500 | $96.99 | $5.5M | +56,500 | +$5.5M | |
| MTZ, Mastec | New | 17,000 | $321.74 | $5.5M | +17,000 | +$5.5M | |
| ENTG, Entegris | New | 45,500 | $117.24 | $5.3M | +45,500 | +$5.3M | |
| C, Citigroup | New | 47,000 | $113.41 | $5.3M | +47,000 | +$5.3M | |
| VNET, Vnet Group | Reduce −90.1% | 623,347 | $8.39 | $5.2M | −5,662,039 | −$48M | |
| H, Hyatt Hotels | New | 36,000 | $143.79 | $5.2M | +36,000 | +$5.2M | |
| WST, Western Alliance Bancorp | New | 73,000 | $70.85 | $5.2M | +73,000 | +$5.2M | |
| TKR, Timken | New | 51,000 | $100.57 | $5.1M | +51,000 | +$5.1M | |
| FLEX, Flextronics International | New | 78,000 | $65.46 | $5.1M | +78,000 | +$5.1M | |
| SPGI, S&P Global | New | 12,000 | $425.34 | $5.1M | +12,000 | +$5.1M | |
| LFUS, Littelfuse | New | 15,000 | $339.35 | $5.1M | +15,000 | +$5.1M | |
| PIPR, Piper Sandler Companies | New | 66,000 | $76.55 | $5.1M | +66,000 | +$5.1M | |
| AIR, Aar | New | 46,000 | $109.46 | $5M | +46,000 | +$5M | |
| RIO, Rio Tinto | New | 53,800 | $93.29 | $5M | +53,800 | +$5M | |
| GTX, Garrett Motion | New | 275,000 | $18.17 | $5M | +275,000 | +$5M | |
| ROL, Rollins | New | 93,000 | $53.41 | $5M | +93,000 | +$5M | |
| AFRM, Affirm | New | 108,000 | $45.82 | $4.9M | +108,000 | +$4.9M | |
| INTR, Inter And | New | 614,500 | $7.96 | $4.9M | +614,500 | +$4.9M | |
| CMI, Cummins | New | 9,000 | $538.02 | $4.8M | +9,000 | +$4.8M | |
| FISV, Fiserv | New | 86,000 | $55.80 | $4.8M | +86,000 | +$4.8M | |
| VRT, Vertiv | New | 19,000 | $250.58 | $4.8M | +19,000 | +$4.8M | |
| AMKR, Amkor Technology | Reduce −77.6% | 104,000 | $45.03 | $4.7M | −360,000 | −$14M | |
| RNA, Atrium Therapeutics | New | 349,360 | $13.37 | $4.7M | +349,360 | +$4.7M | |
| GFS, Globalfoundries | New | 105,000 | $44.48 | $4.7M | +105,000 | +$4.7M | |
| MOH, Molina Healthcare | New | 35,000 | $133.30 | $4.7M | +35,000 | +$4.7M | |
| IRD, Opus Genetics | New | 1,000,000 | $4.55 | $4.6M | +1,000,000 | +$4.6M | |
| TENB, Tenable | New | 265,000 | $16.92 | $4.5M | +265,000 | +$4.5M | |
| PRME, Prime Medicine | Hold | 1,240,843 | $3.48 | $4.3M | — | — | |
| NOW, ServiceNow | New | 41,000 | $104.55 | $4.3M | +41,000 | +$4.3M | |
| SMC, Summit Midstream | Hold | 58,214 | $30.24 | $1.8M | — | — | |
| MDGL, Madrigal Pharmaceuticals | Hold | 3,319 | $523.47 | $1.7M | — | — | |
| CAPR | Hold | 41,000 | $30.40 | $1.2M | — | — | |
| ARWR, Arrowhead Pharmaceuticals | Hold | 15,800 | $62.70 | $991K | — | — | |
| GH, Guardant Health | Reduce −92.7% | 8,000 | $92.37 | $739K | −101,000 | −$10M | |
| ALKS, Alkermes | Hold | 20,800 | $35.36 | $735K | — | — | |
| ALVO, Alvotech | Hold | 199,675 | $3.43 | $685K | — | — | |
| AXSM, Axsome Therapeutics | Hold | 4,000 | $169.02 | $676K | — | — | |
| COGT, Cogent Biosciences | Hold | 17,000 | $38.49 | $654K | — | — | |
| ANNA, Aleanna | Hold | 78,400 | $8.29 | $650K | — | — | |
| ARQT, Arcutis Biotherapeutics | Hold | 26,000 | $23.56 | $613K | — | — | |
| CELC, Celcuity | Hold | 4,000 | $114.14 | $457K | — | — | |
| LIVN, Livanova | Hold | 6,000 | $63.56 | $381K | — | — | |
| TERN, Terns Pharmaceuticals | Reduce −98.9% | 7,000 | $52.72 | $369K | −635,000 | −$26M | |
| IONS, Ionis Pharmaceuticals | Hold | 4,800 | $75.09 | $360K | — | — | |
| TVTX, Travere Therapeutics | Hold | 12,000 | $29.71 | $357K | — | — | |
| GMED, Globus Medical | Hold | 4,000 | $86.16 | $345K | — | — | |
| SRRK, Scholar Rock | Hold | 7,000 | $49.16 | $344K | — | — | |
| ONC, Beone Medicines | Hold | 1,100 | $296.97 | $327K | — | — | |
| WGS, Genedx | Reduce −92.9% | 5,000 | $64.22 | $321K | −65,000 | −$8.8M | |
| COR, Cencora | Hold | 1,000 | $314.14 | $314K | — | — | |
| NUVL, Nuvalent | Hold | 3,000 | $102.45 | $307K | — | — | |
| PGNY, Progyny | Hold | 18,000 | $16.98 | $306K | — | — | |
| STOK, Stoke Therapeutics | Hold | 9,000 | $32.56 | $293K | — | — | |
| EHC, Encompass Health | Reduce −98.7% | 3,000 | $96.73 | $290K | −231,500 | −$25M | |
| GKOS, Glaukos | Hold | 2,600 | $107.66 | $280K | — | — | |
| MIRM, Mirum Pharmaceuticals | Hold | 3,000 | $92.38 | $277K | — | — | |
| SBRA, Sabra Health Care REIT | Hold | 14,000 | $19.23 | $269K | — | — | |
| KRYS, Krystal Biotech | Reduce −50.0% | 1,000 | $258.32 | $258K | −1,000 | −$235K | |
| OMER, Omeros | Hold | 23,000 | $10.56 | $243K | — | — | |
| HQY, Healthequity | Reduce −44.0% | 2,800 | $83.57 | $234K | −2,200 | −$224K | |
| SNDX, Syndax Pharmaceuticals | Hold | 10,000 | $23.36 | $234K | — | — | |
| FOLD, Amicus | Hold | 16,000 | $14.46 | $231K | — | — | |
| QURE, Uniqure | Hold | 14,000 | $16.35 | $229K | — | — | |
| BCRX, Biocryst Pharmaceuticals | Hold | 24,000 | $9.52 | $228K | — | — | |
| VCYT, Veracyte | Hold | 7,000 | $32.21 | $225K | — | — | |
| GRFS, Grifols | Hold | 28,000 | $8.02 | $225K | — | — | |
| ABVX, Abivax | Reduce −99.5% | 2,000 | $111.35 | $223K | −385,000 | −$52M | |
| GEHC, GE HealthCare | Hold | 3,000 | $71.18 | $214K | — | — | |
| HIMS, Hims & Hers Health | Reduce −99.7% | 10,000 | $20.76 | $208K | −3,376,986 | −$110M | |
| MMSI, Merit Medical Systems | Hold | 3,000 | $68.93 | $207K | — | — | |
| HR, Healthcare Realty Trust | Hold | 12,000 | $16.99 | $204K | — | — | |
| URGN, Urogen | Hold | 11,000 | $17.98 | $198K | — | — | |
| PGEN, Precigen | Hold | 50,000 | $3.87 | $194K | — | — | |
| SDGR, Schrodinger | Reduce −76.1% | 17,000 | $11.36 | $193K | −54,000 | −$1.1M | |
| DYN, Dyne Therapeutics | Hold | 10,000 | $18.13 | $181K | — | — | |
| NVAX, Novavax | Reduce −88.7% | 22,000 | $8.14 | $179K | −173,000 | −$1.1M | |
| PACB | Hold | 135,000 | $1.32 | $178K | — | — | |
| ADPT | Hold | 11,000 | $13.88 | $153K | — | — | |
| OCUL, Ocular Therapeutix | Hold | 18,000 | $8.47 | $152K | — | — | |
| NEO, Neogenomics | Hold | 19,000 | $7.42 | $141K | — | — | |
| ARDX, Ardelyx | Hold | 23,000 | $5.99 | $138K | — | — | |
| OSCR, Oscar Health | Reduce −95.8% | 11,000 | $11.47 | $126K | −253,000 | −$3.7M | |
| NUVB, Nuvation Bio | Hold | 29,000 | $4.29 | $124K | — | — | |
| IOVA, Iovance Biotherapeutics | Hold | 26,000 | $3.51 | $91K | — | — | |
| ALT, Altimmune | Hold | 27,600 | $3.08 | $85K | — | — | |
| CCCC, C4 Therapeutics | Hold | 28,000 | $2.63 | $74K | — | — | |
| TVRD, Tvardi Therapeutics | Reduce −50.4% | 21,438 | $3.18 | $68K | −21,787 | −$118K | |
| GERN, Geron | Hold | 43,000 | $1.49 | $64K | — | — | |
| RANI, Rani Therapeutics | Hold | 78,000 | $0.7348 | $57K | — | — | |
| IRWD, Ironwood Pharmaceuticals | Hold | 13,000 | $3.51 | $46K | — | — | |
| EVH, Evolent Health | Hold | 14,000 | $2.28 | $32K | — | — | |
| CGC, Canopy Growth | Hold | 30,000 | $0.9492 | $28K | — | — | |
| BYND, Beyond Meat | Hold | 19,000 | $0.7016 | $13K | — | — |
Showing top 50 of 154 by value
Exits / last held
Gone since 2025 Q4, shown at their last reported size.
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| Cyberark Software | Exit | 0 | $446.06 | $470M | −1,053,040 | −$470M | |
| CRM, Salesforce | Exit | 0 | $264.91 | $334M | −1,261,177 | −$334M | |
| NDAQ, Nasdaq | Exit | 0 | $97.13 | $290M | −2,989,213 | −$290M | |
| NYT, New York Times | Exit | 0 | $69.42 | $228M | −3,280,678 | −$228M | |
| DAY, Dayforce | Exit | 0 | $69.16 | $202M | −2,925,000 | −$202M | |
| CBRE, CBRE Group | Exit | 0 | $160.79 | $158M | −983,771 | −$158M | |
| GBTC, iShares Bitcoin Trust ETF | Exit | 0 | $49.65 | $106M | −2,137,100 | −$106M | |
| CDTX, Cidara Therapeutics | Exit | 0 | $220.89 | $85M | −382,800 | −$85M | |
| TRU, Transunion | Exit | 0 | $85.75 | $58M | −675,000 | −$58M | |
| ETHA, iShares Ethereum Trust | Exit | 0 | $22.43 | $33M | −1,481,001 | −$33M | |
| GPCR, Structure Therapeutics | Exit | 0 | $69.55 | $32M | −454,000 | −$32M | |
| MLYS, Mineralys Therapeutics | Exit | 0 | $36.29 | $30M | −823,296 | −$30M | |
| SUN, Sunococorp | Exit | 0 | $49.28 | $30M | −606,277 | −$30M | |
| VSTM, Verastem | Exit | 0 | $7.72 | $15M | −2,000,000 | −$15M | |
| DOCS, Doximity | Exit | 0 | $44.28 | $14M | −311,000 | −$14M | |
| MDLN, Medline | Exit | 0 | $42.00 | $11M | −260,000 | −$11M | |
| EDU | Exit | 0 | $55.03 | $11M | −196,000 | −$11M | |
| ETH | Exit | 0 | $28.06 | $6.4M | −228,340 | −$6.4M | |
| INSM, Insmed | Exit | 0 | $174.00 | $522K | −3,000 | −$522K | |
| ASND, Ascendis Pharma A/s | Exit | 0 | $213.57 | $299K | −1,400 | −$299K | |
| ACLX, Arcellx | Exit | 0 | $65.25 | $261K | −4,000 | −$261K | |
| SLNO, Soleno Therapeutics | Exit | 0 | $46.40 | $232K | −5,000 | −$232K | |
| ESTA, Establishment Labs | Exit | 0 | $73.00 | $219K | −3,000 | −$219K | |
| ICLR, Icon | Exit | 0 | $182.50 | $219K | −1,200 | −$219K |
Filings history
20 periods, with AUM normalized
| Period | Holds | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 89 | $21.7B | +23.6% | 13F-HR | 8/14/2026 | 000090883426000432 |
| 2026 Q1 | 1 | $1.5B | — | new holds | 8/14/2026 | 000090883426000434 |
| 2026 Q1 | 172 | $17.5B | −17.2% | 13F-HR | 5/15/2026 | 000090883426000240 |
| 2025 Q4 | 1 | $1B | — | new holds | 8/14/2026 | 000090883426000433 |
| 2025 Q4 | 2 | $884M | — | new holds | 5/15/2026 | 000090883426000241 |
| 2025 Q4 | 151 | $21.2B | −13.2% | 13F-HR | 2/17/2026 | 000090883426000087 |
| 2025 Q3 | 144 | $24.4B | — | RESTATEMENT | 2/17/2026 | 000090883426000086 |
| 2025 Q3 | 144 | $24.4B | +5.4% | 13F-HR | 11/14/2025 | 000090883425000353 |
| 2025 Q2 | 1 | $140M | — | new holds | 2/17/2026 | 000090883426000085 |
| 2025 Q2 | 3 | $483M | — | new holds | 11/14/2025 | 000090883425000352 |
| 2025 Q2 | 141 | $23.2B | +29.2% | 13F-HR | 8/14/2025 | 000090883425000248 |
| 2025 Q1 | 1 | $274M | — | new holds | 2/17/2026 | 000090883426000084 |
| 2025 Q1 | 3 | $416M | — | new holds | 11/14/2025 | 000090883425000351 |
| 2025 Q1 | 7 | $2.2B | — | new holds | 8/14/2025 | 000090883425000247 |
| 2025 Q1 | 135 | $17.9B | −9.0% | 13F-HR | 5/15/2025 | 000090883425000177 |
| 2024 Q4 | 1 | $85M | — | new holds | 2/17/2026 | 000090883426000083 |
| 2024 Q4 | 2 | $349M | — | new holds | 11/14/2025 | 000090883425000350 |
| 2024 Q4 | 6 | $2.3B | — | new holds | 8/14/2025 | 000090883425000246 |
| 2024 Q4 | 4 | $333M | — | new holds | 5/15/2025 | 000090883425000180 |
| 2024 Q4 | 138 | $19.7B | −3.5% | 13F-HR | 2/14/2025 | 000090883425000081 |
| 2024 Q3 | 1 | $145M | — | new holds | 11/14/2025 | 000090883425000349 |
| 2024 Q3 | 6 | $1.5B | — | new holds | 8/14/2025 | 000090883425000243 |
| 2024 Q3 | 3 | $216M | — | new holds | 5/15/2025 | 000090883425000179 |
| 2024 Q3 | 2 | $544M | — | new holds | 2/14/2025 | 000090883425000080 |
| 2024 Q3 | 153 | $20.4B | −3.6% | 13F-HR | 11/14/2024 | 000090883424000307 |
| 2024 Q2 | 1 | $120M | — | new holds | 11/14/2025 | 000090883425000348 |
| 2024 Q2 | 5 | $1.2B | — | new holds | 8/14/2025 | 000090883425000245 |
| 2024 Q2 | 1 | $199M | — | new holds | 5/15/2025 | 000090883425000178 |
| 2024 Q2 | 2 | $452M | — | new holds | 2/14/2025 | 000090883425000079 |
| 2024 Q2 | 1 | $149M | — | new holds | 11/14/2024 | 000090883424000324 |
| 2024 Q2 | 157 | $21.2B | −4.2% | 13F-HR | 8/14/2024 | 000090883424000200 |
| 2024 Q1 | 1 | $93M | — | new holds | 11/14/2025 | 000090883425000347 |
| 2024 Q1 | 4 | $1.2B | — | new holds | 8/14/2025 | 000090883425000244 |
| 2024 Q1 | 2 | $159M | — | new holds | 2/14/2025 | 000090883425000078 |
| 2024 Q1 | 1 | $45M | — | new holds | 8/14/2024 | 000090883424000202 |
| 2024 Q1 | 167 | $22.1B | — | RESTATEMENT | 5/24/2024 | 000090883424000159 |
| 2024 Q1 | 167 | $22.1B | +9.8% | 13F-HR | 5/15/2024 | 000090883424000135 |
| 2023 Q4 | 1 | $65M | — | new holds | 11/14/2025 | 000090883425000346 |
| 2023 Q4 | 2 | $548M | — | new holds | 8/14/2025 | 000090883425000250 |
| 2023 Q4 | 5 | $1.1B | — | new holds | 5/15/2024 | 000090883424000141 |
| 2023 Q4 | 150 | $20.1B | +1.0% | 13F-HR | 2/14/2024 | 000090883424000070 |
| 2023 Q3 | 1 | $40M | — | new holds | 11/14/2025 | 000090883425000345 |
| 2023 Q3 | 1 | $40M | — | new holds | 5/15/2024 | 000090883424000138 |
| 2023 Q3 | 2 | $1.4B | — | new holds | 2/14/2024 | 000090883424000077 |
| 2023 Q3 | 1 | $1.9B | — | new holds | 2/12/2024 | 000090883424000049 |
| 2023 Q3 | 159 | $20B | +11.5% | 13F-HR | 11/14/2023 | 000090883423000150 |
| 2023 Q2 | 2 | $669M | — | new holds | 2/14/2024 | 000090883424000076 |
| 2023 Q2 | 5 | $1.4B | — | new holds | 11/14/2023 | 000090883423000157 |
| 2023 Q2 | 1 | $1.2B | — | new holds | 10/26/2023 | 000090883423000134 |
| 2023 Q2 | 165 | $17.9B | +1.3% | 13F-HR | 8/14/2023 | 000090883423000109 |
| 2023 Q1 | 2 | $234M | — | new holds | 2/14/2024 | 000090883424000075 |
| 2023 Q1 | 3 | $389M | — | new holds | 11/14/2023 | 000090883423000156 |
| 2023 Q1 | 1 | $15M | — | new holds | 8/14/2023 | 000090883423000110 |
| 2023 Q1 | 187 | $17.7B | +15.8% | 13F-HR | 5/15/2023 | 000117570723000127 |
| 2022 Q4 | 1 | $171M | — | new holds | 2/14/2024 | 000090883424000074 |
| 2022 Q4 | 3 | $485M | — | new holds | 11/14/2023 | 000090883423000155 |
| 2022 Q4 | 7 | $1B | — | new holds | 5/15/2023 | 000117570723000136 |
| 2022 Q4 | 232 | $15.3B | −9.3% | 13F-HR | 2/14/2023 | 000117570723000051 |
| 2022 Q3 | 1 | $125M | — | new holds | 2/14/2024 | 000090883424000073 |
| 2022 Q3 | 3 | $415M | — | new holds | 11/14/2023 | 000090883423000154 |
| 2022 Q3 | 5 | $411M | — | new holds | 5/15/2023 | 000117570723000135 |
| 2022 Q3 | 4 | $434M | — | new holds | 2/14/2023 | 000090966123000005 |
| 2022 Q3 | 298 | $16.8B | +3.5% | 13F-HR | 11/14/2022 | 000156761922019851 |
| 2022 Q2 | 1 | $115M | — | new holds | 2/14/2024 | 000090883424000081 |
| 2022 Q2 | 3 | $411M | — | new holds | 11/14/2023 | 000090883423000153 |
| 2022 Q2 | 2 | $337M | — | new holds | 5/15/2023 | 000117570723000134 |
| 2022 Q2 | 3 | $136M | — | new holds | 2/14/2023 | 000090966123000003 |
| 2022 Q2 | 9 | $1.2B | — | new holds | 11/14/2022 | 000156761922019862 |
| 2022 Q2 | 297 | $16.3B | −13.7% | 13F-HR | 8/15/2022 | 000156761922015953 |
| 2022 Q1 | 1 | $268M | — | new holds | 11/14/2023 | 000090883423000152 |
| 2022 Q1 | 1 | $314M | — | new holds | 5/15/2023 | 000117570723000133 |
| 2022 Q1 | 1 | $27M | — | new holds | 2/14/2023 | 000090966123000002 |
| 2022 Q1 | 3 | $186M | — | new holds | 11/14/2022 | 000156761922019864 |
| 2022 Q1 | 8 | $1.1B | — | new holds | 8/15/2022 | 000156761922015972 |
| 2022 Q1 | 307 | $18.8B | +0.4% | 13F-HR | 5/16/2022 | 000156761922010736 |
| 2021 Q4 | 1 | $227M | — | new holds | 5/15/2023 | 000117570723000132 |
| 2021 Q4 | 1 | $7M | — | new holds | 11/14/2022 | 000156761922019852 |
| 2021 Q4 | 1 | $115M | — | new holds | 8/15/2022 | 000156761922015968 |
| 2021 Q4 | 2 | $98M | — | new holds | 5/19/2022 | 000156761922011257 |
| 2021 Q4 | 6 | $833M | — | new holds | 5/16/2022 | 000156761922010757 |
| 2021 Q4 | 289 | $18.7B | −5.1% | 13F-HR | 2/14/2022 | 000156761922003965 |
| 2021 Q3 | 1 | $182M | — | new holds | 5/15/2023 | 000117570723000131 |
| 2021 Q3 | 1 | $105M | — | new holds | 8/15/2022 | 000156761922015964 |
| 2021 Q3 | 1 | $57M | — | new holds | 5/19/2022 | 000156761922011256 |
| 2021 Q3 | 3 | $998M | — | new holds | 5/16/2022 | 000156761922010753 |
| 2021 Q3 | 2 | $344M | — | new holds | 2/14/2022 | 000156761922003981 |
| 2021 Q3 | 293 | $19.7B | — | 13F-HR | 11/15/2021 | 000095012321015168 |
About
Farallon Capital Management, L.l.c.
87 processed 13Fs on this site, 2021 Q3 to 2026 Q2